Welcome to our dedicated page for Amedisys news (Ticker: AMED), a resource for investors and traders seeking the latest updates and insights on Amedisys stock.
Amedisys, Inc. (NASDAQ: AMED) is a healthcare at home company that reports on developments across home health, hospice and high acuity care services delivered in the home. The Amedisys news flow includes regular earnings announcements, corporate updates and clinical program disclosures that reflect its role in the home health care services industry.
Investors and observers following AMED news can expect detailed quarterly and annual financial results, including net service revenue, net income, adjusted EBITDA and other non-GAAP measures that Amedisys reconciles to GAAP in its releases. These earnings communications often discuss factors such as merger-related expenses, impairment charges and other items that affect reported and adjusted results.
Amedisys also issues news about its clinical initiatives and partnerships. For example, the company has announced the rollout of advanced molecular testing for infection diagnosis in collaboration with Patient Choice Laboratories, aimed at improving the speed and accuracy of identifying pathogens in urine, respiratory and wound infections in the home setting. Through its subsidiary Contessa Health, Amedisys has highlighted participation in models such as the Centers for Medicare & Medicaid Services’ GUIDE Model for dementia care, reflecting activity in alternative payment and care delivery models.
Other Amedisys news items cover recognition for patient and caregiver satisfaction, such as SHPBest™ awards for home health and hospice care centers, and updates related to its merger with UnitedHealth Group, including regulatory and legal milestones. Readers who monitor AMED news gain insight into the company’s financial performance, regulatory environment, care quality indicators and the evolution of its home-based service offerings.
Amedisys, a leader in home health and hospice services, will announce its financial results for the fourth quarter and full year ending December 31, 2022, on February 15, 2023. The investor conference call is scheduled for February 16, 2023, at 11:00 a.m. ET. Callers can join via toll-free (877) 524-8416 or (412) 902-1028. A replay will be available until March 16, 2023. Amedisys provides personalized care through a network of over 532 care centers, catering to more than 465,000 patients annually. Founded in 1982, the company employs roughly 20,000 staff nationwide.
Amedisys, a prominent provider of home health and hospice services, will be presenting at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 8:15 p.m. ET. CEO Paul B. Kusserow will represent the company during this event, which is pivotal for stakeholders and investors. Interested parties can access the live webcast of Amedisys’ presentation by visiting their investor relations website. Amedisys specializes in personalized care services across various healthcare settings and serves over 445,000 patients annually.
Amedisys, Inc. (NASDAQ: AMED) has been recognized as one of the top home health and hospice companies by Computerworld in its 2023 Best Places to Work in IT ranking, placing 34th among large organizations. This accolade highlights Amedisys's commitment to employee engagement through excellent compensation, training, and technology access. The rankings are determined through a comprehensive survey of IT professionals and company offerings, underscoring the company’s dedication to creating a supportive work environment for its IT staff.
Amedisys has finalized a joint venture with the University of Arkansas for Medical Sciences (UAMS) to enhance home health services in Searcy and Little Rock, Arkansas. This collaboration offers a range of clinical services under the UAMS Health Comprehensive Care at Home program, including Recovery, Rehabilitation, and Palliative Care. Amedisys now operates 353 care centers across 35 states with approximately 70,000 patients daily. The company's commitment to quality is reflected in its 4.44 QPC Star score and recognition as a top workplace in healthcare.
Summary not available.
Amedisys, a provider of home health, hospice, and personal care, announced that CEO Paul B. Kusserow and COO Scott Ginn will present at the Bank of America Securities Home Care Conference on December 6, 2022, at 9 a.m. ET. The presentation will be available via live webcast on the company's investor relations website.
Amedisys, founded in 1982 and headquartered in Baton Rouge, LA, delivers care to over 445,000 patients annually, with approximately 21,000 employees and 547 care centers across 36 states.
Amedisys, Inc. (NASDAQ: AMED) has appointed Scott Ginn as Acting Chief Operating Officer, effective immediately. Ginn, who has been with the company since 2007, will retain his role as Chief Financial Officer while overseeing home health, hospice, and personal care operations. Chairman and CEO Paul Kusserow expressed confidence in Ginn's leadership to deliver strong results. Amedisys is a leading provider of home healthcare services, catering to over 445,000 patients annually across 36 states, showcasing its commitment to high-quality care.
Amedisys, Inc. (NASDAQ: AMED) announced a leadership change on November 17, 2022, with CEO Chris Gerard departing and Paul Kusserow, Chair of the Board, stepping in as interim CEO. The company confirmed its full-year guidance, indicating it is on track to meet previously released targets. Amedisys provides various healthcare services at home, partnering with over 3,000 hospitals and 90,000 physicians, serving more than 445,000 patients annually.
Amedisys (NASDAQ: AMED) announced on November 17, 2022, that President and CEO Chris Gerard has left the company. Paul Kusserow, former CEO, will take over as Chairman and CEO until a new leader is selected. The board expressed confidence in Kusserow's ability to drive profitable growth and innovation. The company is initiating an executive search for Gerard's replacement. Amedisys is a leading home healthcare provider, servicing over 445,000 patients annually with approximately 21,000 employees across 36 states.
Amedisys, Inc. (NASDAQ: AMED) responded to the CY 2023 Home Health Final Rule released by CMS, stating it is an improvement over prior proposals. The rule includes a 4.0% market basket update, the highest for home health agencies, and reduces behavioral adjustment cuts by half. Amedisys acknowledges the support from Congress and advocates in the healthcare community while expressing ongoing concerns about the CMS's budget neutrality methodology. The company remains committed to working with stakeholders to ensure sustainable Medicare payment policies for home health services.